Clinical Research & Evidence Key Study: The SURMOUNT-1 Trial Published in The New England Journal of Medicine , the SURMOUNT-1 trial followed 2,539 adults with obesity over 72 weeks
doi: 10.1038/s41573-019-0051-2 211 MorganMABuningHSauerMSchambachA
Phase 2 trial data suggest early appetite changes may emerge within the first two to four weeks, with measurable weight loss typically becoming apparent between weeks four and twelve
BPC-157 is gebleken bijwerkingen van NSAIDs, medicijnen die worden gebruikt bij psychiatrische aandoeningen, en een aantal hartmedicijnen tegen te gaan
Book your appointment today and start feeling revitalised.
Raised levels of homocysteine are also linked to Alzheimers, dementia, declining memory, poor concentration and judgment and lowered mood